Andres Lisker-Cervantes

Andres Lisker-Cervantes

Auto-generated profile, based on publicly available information

Andres Lisker-Cervantes

Sue Anschutz-Rodgers Eye Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
EHEverardo Hernandez-Quintela
Everardo Hernandez-Quintela
AGAnat Galor
Anat Galor
NRNallely Ramos-Betancourt
Nallely Ramos-Betancourt
ALAndres Lisker-Cervantes
Andres Lisker-Cervantes
FBFrancisco Beltran
Francisco Beltran
Jaime D. MartinezJaime D. Martinez
Jaime D. Martinez
Purpose: The purpose of this study was to ascertain the frequency and risk factors of dry eye (DE) among patients attending a tertiary care ophthalmology center in Mexico. Methods: Approximately 338 consecutive new patients attending a tertiary care ophthalmology center in Mexico City underwent an ocular surface examination, which included tear film break-up time, fluorescein corneal staining, Schirmer’s test, and evaluation of meibum quality. Symptoms of DE were evaluated by the Ocular Surface Disease Index and Dry Eye Questionnaire-5. Information on demographics, exposures, past medical and ocular history, and medications was also collected. Results: The frequency of severe DE symptoms was found to be 43% based on the Ocular Surface Disease Index and 30% based on Dry Eye Questionnaire-5. Risk factors significantly associated with increased DE symptoms included dry mouth and gastrointestinal ulcer medications. With regard to signs, aqueous tear deficiency was a less-frequent finding (22%) in our population than evaporative deficiency (94%). Risk factors associated with aqueous tear deficiency were dry mouth and diuretic use. No risk factors were associated with evaporative deficiency. Risk factors associated with meibomian gland dysfunction included old age, male sex, arthritis, and use of an antihypertensive. The only risk factor associated with corneal staining was dry mouth. Conclusion: This is the first study to demonstrate the frequency of symptomatic and clinical DE in a tertiary care ophthalmology center in Mexico. The frequency of DE ranged from 30% using a symptomatic definition to 94% using objective measures. Different risk factors were found for different aspects of DE, suggesting differing underlying pathophysiologies behind different DE subtypes.

1 April 2014 in Sexual Medicine
Verified
Journal Article
Open access
PDF file
GRGustavo Romero-Velez
Gustavo Romero-Velez
ALAndrés Lisker-Cervantes
Andrés Lisker-Cervantes
CVChristian I. Villeda-Sandoval
Christian I. Villeda-Sandoval
MZMariano Sotomayor de Zavaleta
Mariano Sotomayor de Zavaleta
DODaniel Olvera-Posada
Daniel Olvera-Posada
RCRicardo A. Castillejos-Molina
Ricardo A. Castillejos-Molina
Objective To assess the prevalence and risk factors of erectile dysfunction (ED) in HIV patients from the HIV clinic of a tertiary referral center in Mexico City. Design Prevalence was obtained from cross‐sectional studies, and the International Index of Erectile Function (IIEF), a standardized method, was used to assess ED. Methods A cross‐sectional study was performed in the HIV clinic. Participants completed the IIEF to allow ED assessment. Information on demographics, clinical and HIV‐related variables was retrieved from their medical records. Results One hundred and nine patients were included, with a mean age of 39.9 ± 8.8 years. ED was present in 65.1% of the individuals. Patients had been diagnosed with HIV for a mean of 92.7 ± 70.3 months and had undergone a mean 56.4 ± 45.5 months of HAART. The only variable associated with ED in the univariate analysis was dyslipidemia, and this association was also found in the multivariate analysis (P = 0.01). Conclusions ED is highly prevalent in HIV patients. Dyslipidemia should be considered as a risk factor for ED in HIV patients. Romero‐Velez G, Lisker‐Cervantes A, Villeda‐Sandoval CI, Sotomayor de Zavaleta M, Olvera‐Posada D, Sierra‐Madero JG, Arreguin‐Camacho LO, and Castillejos‐Molina RA. Erectile dysfunction among HIV patients undergoing highly active antiretroviral therapy: Dyslipidemia as a main risk factor. Sex Med 2014;2:24–30.

27 March 2024 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
TFTalisa E. de Carlo Forest
Talisa E. de Carlo Forest
ZGZafar Gill
Zafar Gill
ALAndres Lisker-Cervantes
Andres Lisker-Cervantes
RGRamya Gnanaraj
Ramya Gnanaraj
NGNathan Grove
Nathan Grove
NMNaresh Mandava
Naresh Mandava

1 November 2018 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
GSGuillermo Salcedo-Villanueva
Guillermo Salcedo-Villanueva
EFEstephania Feria-Anzaldo
Estephania Feria-Anzaldo
JRJuan C. Romo-Aguas
Juan C. Romo-Aguas
ALAndrés Lisker-Cervantes
Andrés Lisker-Cervantes
AGAlejandra González-Dibildox
Alejandra González-Dibildox
HQHugo Quiroz-Mercado
Hugo Quiroz-Mercado

17 January 2022 in Ophthalmic Genetics
Verified
Journal Article
Closed access
ATAlan Baltazar Treviño-Herrera
Alan Baltazar Treviño-Herrera
ABAna Patricia Bustamante-Vargas
Ana Patricia Bustamante-Vargas
ALAndrés Lisker-Cervantes
Andrés Lisker-Cervantes
DVDolores Ríos Y Valles Valles
Dolores Ríos Y Valles Valles
CVCristina Villanueva-Mendoza
Cristina Villanueva-Mendoza
LCLuz Elena Concha-Del-Río
Luz Elena Concha-Del-Río
Hereditary transthyretin amyloidosis (ATTR) is a multisystemic disease with autosomal dominant inheritance, characterized by the deposition of amyloid-insoluble proteins. We describe a case of vitreous amyloidosis as the initial presentation of ATTRv amyloidosis resulting from the rare Ile107Met (p.Ile127Met) pathogenic variant. Ophthalmic examination, multimodal imaging, vitreous biopsy, and genetic testing were performed to confirm the diagnosis. A 44-year-old woman presented with blurred vision and floaters in both eyes (OU) for 1 year. The vitreous showed numerous strand-like opacities that were predominant in the anterior vitreous of OU. After a systemic workup and excluding malignancy, vitreous amyloidosis was suspected. Pars plana vitrectomy (PPV) of the left eye (OS) was performed, and a vitreous sample was obtained for histopathology. Homogeneous eosinophilic granular and filamentous deposits that showed an orange–red color with Congo red special stain were observed in the vitreous material, confirming vitreous amyloidosis. A PPV for the right eye (OD) was performed, and her vision at discharge was 20/20 OU. Systemic evaluation discarded neurologic or other systemic manifestations; however, there was familiar involvement in three generations with neurologic symptomatology, confirming an autosomal dominant inheritance pattern. Molecular analysis of the TTR gene showed a likely pathogenic variant Ile107Met (p.Ile127Met). The present report describes a patient with ATTRv amyloidosis with initial vitreous involvement and the pathogenic variant Ile107Met (p.Ile127Met). It is important to consider vitreous amyloidosis as part of the non-malignant, non-infectious uveitis masquerade syndromes.

1 September 2013 in International braz j urol
Verified
Journal Article
Open access
PDF file
CVChristian I. Villeda-Sandoval
Christian I. Villeda-Sandoval
GRGustavo Romero-Velez
Gustavo Romero-Velez
ALAndres Lisker-Cervantes
Andres Lisker-Cervantes
MZMariano Sotomayor de Zavaleta
Mariano Sotomayor de Zavaleta
ATAlicia Trolle-Silva
Alicia Trolle-Silva
RCRicardo Castillejos-Molina
Ricardo Castillejos-Molina
Key words: Bulbourethral Glands; Cysts; Cystadenoma